Company

Mission

We are pioneering neuroprotection using acute omega-3 fatty acid therapeutics.

Therapeutic Platform 

DeckTherapeutics is pioneering the new field of “acute omega-3 fatty acid therapeutics”. Emulsions of our proprietary semi-synthetic omega-3 compounds are administered intravenously and exert immediate effect on multiple molecular pathways critical for controlling cellular apoptosis and necrosis.

More than a decade of in-vitro and in-vivo studies at Dr. Deckelbaum’s laboratory at Columbia University indicate that the emulsions are particularly effective as neuroprotectants after hypoxic-ischemic or hypoxia-reperfusion events in adults or neonates, but the emulsions have also shown great potential in tissue protection after acute myocardial infarction, acute renal injury, spinal cord injury as well as in complex metabolic dysfunctions such as non-alcoholic steatohepatitis.

Leadership Team

DeckTherapeutics’ leadership team brings together decades of experience and world-class science in the areas of omega-3 chemistry and biology and in drug and business development.

FOUNDING SCIENTIST & SAB CHAIR
Richard J. Deckelbaum
Chief Executive Officer
Soren Weis Dahl
CHIEF OPERATING OFFICER
Suman Lal
VP CHEMISTRY
Jaroslav Kralovec

Board of Directors

DeckTherapeutics’ Board comprises leading experts with background in basic and translational research, technology commercialization, clinical trials and industry partnerships, and venture capital. We are in the process of recruiting senior industry executives to the board, so stay tuned.

CHAIR
Dan Deckelbaum
Non-Executive Officer
William Chin
Chief Executive Officer
Soren Weis Dahl

Scientific Advisory Board

DeckTherapeutics has established a Scientific Advisory Board comprised of some of the world’s foremost clinician scientists and practitioners in the area of treating brain injury following hypoxic-ischemia.

COLUMBIA UNIVERSITY
Richard J. Deckelbaum
BRIGHAM AND WOMEN’S HOSPITAL
Terrie Inder
UCSF
Donna Ferriero
BOSTON CHILDREN’S HOSPITAL
Janet Soul
Yale School of Medicine
Kevin Sheth
Columbia University
Ken Cheung